RESUMO
A 44-year-old man with recurrent lung cancer was readmitted to the hospital for chemotherapy. He was first treated by chemotherapy of CDDP + etoposide, after which the chemotherapy was changed to a regimen of weekly paclitaxel because of his desire to work. He could then be discharged from the hospital and return to his work. No side effects of this frequent schedule on his immune function were noted. He is now doing well and working. The regimen of weekly paclitaxel seemed to be effective in improving QOL because that regimen allowed him to work.
Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos Fitogênicos/administração & dosagem , Neoplasias Pulmonares/tratamento farmacológico , Recidiva Local de Neoplasia/tratamento farmacológico , Paclitaxel/administração & dosagem , Adenocarcinoma/cirurgia , Adulto , Esquema de Medicação , Humanos , Neoplasias Pulmonares/cirurgia , Masculino , Qualidade de VidaRESUMO
A 68-year-old man with recurrent lung cancer was treated with chemotherapy of weekly gemcitabine and vinorelbine on an outpatient basis. After 2 cycles of the regimen, shadows in the lung completely disappeared. During this treatment, the patient's condition was good. This regimen seems to be effective in maintaining QOL and may be suitable for outpatients.
